Lokken Investment Group LLC Eli Lilly & CO Transaction History

Lokken Investment Group LLC

$226 Million
Q3 2024

A detailed history of Lokken Investment Group LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Lokken Investment Group LLC holds 4,169 shares of LLY stock, worth $3.12 Million. This represents 1.63% of its overall portfolio holdings.

Number of Shares

4,169

Previous 4,199 0.71%

Holding current value

$3.12 Million

Previous $3.8 Million 2.84%

% of portfolio

1.63%

Previous 1.86%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $23,164 - $28,800	-30 Reduced 0.71%	4,169 $3.69 Million
Q2 2024 Aug 09, 2024	SELL	$724.87 - $909.04 $244,281 - $306,346	-337 Reduced 7.43%	4,199 $3.8 Million
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $132,652 - $177,470	-224 Reduced 4.71%	4,536 $3.53 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $1,738 - $2,397	-4 Reduced 0.08%	4,760 $2.56 Million
Q2 2023 Aug 09, 2023	SELL	$350.74 - $468.98 $53,663 - $71,753	-153 Reduced 3.11%	4,764 $2.23 Million
Q1 2023 May 08, 2023	SELL	$310.63 - $364.82 $29,509 - $34,657	-95 Reduced 1.9%	4,917 $1.69 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $22,830 - $26,601	71 Added 1.44%	5,012 $1.83 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $296 - $337	1 Added 0.02%	4,941 $1.6 Million
Q2 2022 Aug 08, 2022	SELL	$278.73 - $327.27 $29,545 - $34,690	-106 Reduced 2.1%	4,940 $1.6 Million
Q1 2022 May 11, 2022	BUY	$234.69 - $291.66 $9,387 - $11,666	40 Added 0.8%	5,046 $1.47 Million
Q4 2021 Feb 07, 2022	BUY	$224.85 - $279.04 $87,241 - $108,267	388 Added 8.4%	5,006 $1.38 Million
Q3 2021 Nov 05, 2021	SELL	$221.6 - $272.71 $27,478 - $33,816	-124 Reduced 2.61%	4,618 $1.07 Million
Q2 2021 Aug 03, 2021	BUY	$180.55 - $233.54 $180 - $233	1 Added 0.02%	4,742 $1.09 Million
Q1 2021 Jun 10, 2021	SELL	$164.32 - $212.72 $68,850 - $89,129	-419 Reduced 8.12%	4,741 $886,000
Q4 2020 Feb 08, 2021	BUY	$130.46 - $172.63 $54,662 - $72,331	419 Added 8.84%	5,160 $871,000
Q1 2012 Apr 13, 2021	BUY	N/A	4,741	4,741 $886,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lokken Investment Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lokken Investment Group LLC with notifications on news.

Account

Lokken Investment Group LLC Eli Lilly & CO Transaction History